Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
Related BPC-157 Research Compounds Researchers working with the BPC-157 TB-500 blend may also be interested in these related compounds from our catalogue: BPC-157 5mg standalone BPC-157 for isolated single-compound research protocols BPC-157 10mg higher dosage standalone vial for extended research cycles BPC-157 15mg maximum standalone dosage for high-concentration laboratory studies BPC-157 + TB-500 20mg Blend double-strength version of this formulation for extended protocols BPC-157 + TB-500 + GHK-Cu 30mg Glow Blend triple-compound blend adding copper peptide for extracellular matrix research All compounds are independently tested by Janoshik Analytical and supplied with batch-specific COA documentation
Combined use produces approximately 30-60% better outcomes versus either peptide alone according to community reports
This makes it a candidate for oral or subcutaneous delivery depending on the goal
Bone fractures mend more quickly
However, no completed human clinical trials exist, and the compound has not entered formal drug development
We utilize High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to confirm an absolute chemical purity profile of 99% or greater across both active chemical compounds within the matrix
US$ 21.23
US$ 28.43
US$ 22.14
US$ 21.46
